Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pediatric Study Timelines Could Change Under Senate PDUFA Bill

09 May 2017

• By Sue Sutter

Related Content

First Draft FDA User Fee Bill Is Squeaky Clean

14 Apr 2017

Senate's User Fee Bill Largely Steers Clear Of Controversy

09 May 2017

Pediatric Drug Development A Priority For US FDA’s New Oncology Center Of Excellence

22 Feb 2017

PDUFA VI: Pediatrics Group Seeks Earlier And Faster Studies

17 Mar 2017

Pediatric Study Requirements For Cancer Have FDA Support, But Pose Industry Challenges

03 Aug 2016

Additional Topics

United States Legislation Drug Approval Standards Regulation BioPharmaceutical

More from Legislation

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.